Targeted therapy in Turkey generally costs between AUD $1,445 and AUD $6,645 per session. Final expenses depend on the specific molecular markers, drug choice, and necessary diagnostic profiling. Australians typically find the average local price of AUD $16,180 significantly higher, with Turkey offering savings of approximately 75%. Standard inclusions often cover oncologist consultations and airport transfers.
Bookimed Expert Insight: Australian patients gain significant value by accessing multidisciplinary tumor boards at top Istanbul facilities. Anadolu Medical Center, for example, maintains an affiliation with Johns Hopkins Hospital, meaning Western-standard protocols cost much less. Larger institutions like Memorial Göztepe Hospital use AI-supported 3 Tesla MRI and digital PET/CT to refine dosage. This precision often reduces wasted medication costs during treatment.
| Turkey | Thailand | South Korea | |
| Targeted therapy | from AUD $1,445 | from AUD $10,113 | from AUD $7,946 |
| Lutetium-177 therapy | from AUD $12,713 | from AUD $17,336 | from AUD $19,503 |
| Oncothermia | from AUD $650 | from AUD $5,201 | - |
| Actinium-225 Therapy | from AUD $33,162 | from AUD $36,117 | - |
No hidden fees – just official clinic prices. Pay at the clinic for Targeted therapy upon arrival and use a flexible instalment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Targeted therapy and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Targeted therapy journey.
Dr. Bulent Karagoz is a medical oncologist at Anadolu Medical Center in Istanbul. He specializes in immunotherapy and targeted therapies for sarcoma, lymphoma, and lung cancer. Dr. Karagoz provides treatment at a facility affiliated with the prestigious Johns Hopkins Hospital.
Dr. Eda Tanrikulu is a clinical oncologist at Anadolu Medical Center in Istanbul. She ranked 3rd nationally in Turkey's minor specialty medical exam. Dr. Tanrikulu specializes in chemotherapy and individualized cancer treatments. She works at a facility affiliated with the Johns Hopkins Hospital.
Professor Mustafa Solak gained elite clinical oncology experience at the University of Texas MD Anderson Cancer Center, world-renowned for developing targeted cancer therapies.
Dr. Sinan Karaaslan is a medical oncologist at Anadolu Medical Center in Istanbul. He specializes in treating breast, colorectal, and urogenital system cancers. Dr. Karaaslan brings clinical expertise from major institutions, including Medical Park and Gülhane Military Medical Academy. He works at a hospital affiliated with the Johns Hopkins Hospital.
When considering Targeted therapy, it’s important to understand the different techniques and which is best suited for you. Here’s a concise comparison of popular options:
Lutetium-177 therapy is a targeted radiotherapy utilizing the Lutetium-177 radioisotope to treat certain cancers effectively.